PhaseV

📍 Boston, United States👥 18 employees💰 Last funded Jul 2023
PhaseV is leveraging cutting-edge algorithms such as reinforcement learning and causal ML for adaptive trial design and closed-loop execution, in order to improve trial success rate while maximizing resource and time efficiency. Our novel methodology and advanced technology also enable the detection of hidden signals in data while analyzing clinical trial results and extracting actionable insights.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
Israel
2
United States
1
Frequently asked questions
Who invested in PhaseV?
PhaseV has 3 investors on record on gritt.io.
When did PhaseV last raise funding?
The most recent investment in PhaseV recorded on gritt.io was in July 2023.
What industry is PhaseV in?
PhaseV operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is PhaseV based?
PhaseV is headquartered in Boston, United States.